Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Miura

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
BMC Cancer|October 21, 2015
Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014Yusuke Takagi, Yukio Hosomi, Fumihiro Oshita, et al.
Clinical Case Reports|October 13, 2025
Efficacy of Dupilumab in a Woman With Severe Asthma Complicated by Eosinophilic Sinusitis and a Desire to Have a Baby: A Case ReportAkari Neoi, Masakiyo Yatomi, Yurino Nagata, et al.
Breathe (Sheffield, England)|November 7, 2022
A pregnant woman with severe dyspnoeaMio Kanbe, Masakiyo Yatomi, Ikuo Wakamatsu, et al.
Respiratory Medicine Case Reports|March 23, 2023
Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforationMari Sato, Masakiyo Yatomi, Ikuo Wakamatsu, et al.
Thoracic Cancer|July 20, 2023
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexedHisao Imai, Satoshi Wasamoto, Takeshi Tsuda, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2015
First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutationsTomohito Kuwako, Hisao Imai, Tomomi Masuda, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2017
Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancerHisao Imai, Tomohito Kuwako, Kyoichi Kaira, et al.
Oncology|August 20, 2023
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-PaclitaxelFuyumi Nishihara-Kato, Hisao Imai, Takeshi Tsuda, et al.
Clinical Case Reports|April 17, 2026
Exogenous Lipoid Pneumonia Caused by E-Cigarette Use Following Exposure to Oil Spray and Waterproofing Spray: A Case ReportIkuo Wakamatsu, Masakiyo Yatomi, Yuya Kuroiwa, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2020
Phase I/II study of carboplatin plus weekly nab-paclitaxel in patients aged ≥75 years with squamous-cell lung cancer: TORG1322Yoshitaka Zenke, Seiji Niho, Shigeki Umemura, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
BMC Cancer|October 21, 2015
Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014Yusuke Takagi, Yukio Hosomi, Fumihiro Oshita, et al.
Clinical Case Reports|October 13, 2025
Efficacy of Dupilumab in a Woman With Severe Asthma Complicated by Eosinophilic Sinusitis and a Desire to Have a Baby: A Case ReportAkari Neoi, Masakiyo Yatomi, Yurino Nagata, et al.
Breathe (Sheffield, England)|November 7, 2022
A pregnant woman with severe dyspnoeaMio Kanbe, Masakiyo Yatomi, Ikuo Wakamatsu, et al.
Respiratory Medicine Case Reports|March 23, 2023
Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforationMari Sato, Masakiyo Yatomi, Ikuo Wakamatsu, et al.
Thoracic Cancer|July 20, 2023
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexedHisao Imai, Satoshi Wasamoto, Takeshi Tsuda, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2015
First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutationsTomohito Kuwako, Hisao Imai, Tomomi Masuda, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2017
Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancerHisao Imai, Tomohito Kuwako, Kyoichi Kaira, et al.
Oncology|August 20, 2023
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-PaclitaxelFuyumi Nishihara-Kato, Hisao Imai, Takeshi Tsuda, et al.
Clinical Case Reports|April 17, 2026
Exogenous Lipoid Pneumonia Caused by E-Cigarette Use Following Exposure to Oil Spray and Waterproofing Spray: A Case ReportIkuo Wakamatsu, Masakiyo Yatomi, Yuya Kuroiwa, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2020
Phase I/II study of carboplatin plus weekly nab-paclitaxel in patients aged ≥75 years with squamous-cell lung cancer: TORG1322Yoshitaka Zenke, Seiji Niho, Shigeki Umemura, et al.
Pageof 5